1Unwin N,Shaw J,Zimmet P,et al.Impaired glucose tolerance and impaired fasting glycaemia:The current status on definition and intervention [J].Diabet Med,2002;19 (9) :708-723.
2Kanauchi M,Nakajima M,Saito Y,et al.Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus [J].Metabolism,2003;52 (4):476-481.
3Hffner SM,Gonzalez C,Miettinen H,et al.A prospective analysis of the HOMA model.The mexico city diabetes study [J].Diabetes Care,1996;19:1138-1141.
4Drivsholm T,Ibsen H,Schroll M,et al.Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes [J].Diabet Med,2001;18(2):126-132.
5Pietropaolo M,Barinas-Mitchell E,Pietropaolo SL,et al.Evidence of islet cellautoimmunity in elderly patients with type 2 diabetes [J].Diabetes,2000;49 (1):32-38.
6Elbein SC, Wegner K, Kahn SE Reduced β-cell compensation to the insulin resistance associated with obesity in members of Caucasian familial type 2 diabetic kindreds. Diabetes Care 2000;23:221 -7
7Pratley RE, Weyer C. Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion. Curr Diab Rep 2002;2 (3): 148-224
8Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 ;344(18): 1343 - 50
9Pan XR, Li GW, Hu HY, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care 1997 ;20:537
10Del Prato S, Tiengo A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 2001; 17:164-74
